Home

Prescribing & Medicines Management
page PM1
March 2004


Features


Pharmacists and GPs work together to support benzodiazepine withdrawal

Many patients want to stop taking benzodiazepines. Debbie Andalo finds out how they can be helped

Many programmes have been developed to help patients stop taking benzodiazepines and, in one of the latest, a practice pharmacist and a GP have successfully been working together.

In a pilot — which is due to be extended across a primary care trust area — around 50 per cent of those patients who had been on the drugs long-term, and wanted to stop taking them, have done so. GPs at the practice in Cleveland have in the past offered benzodiazepines on a 14-day acute prescription but they were keen to reach those patients who had been on repeat prescriptions for a long time. Since the pilot was launched two years ago, six of the 16 practices in Langbaurgh Primary Care Trust have also developed a partnership with their support pharmacist to tackle benzodiazepine use.

Now the PCT is planning to employ a specialist mental health nurse to work across all practices to give extra support to the pharmacists and GPs to tackle the problem of those patients who have been on benzodiazepines long term.

The initiative coincides with plans by chief medical officer in England Sir Liam Donaldson to introduce “installment dispensing” for benzodiazepines where pharmacists, relying on a GP’s single prescription, can dispense the drug daily in an attempt to reduce patient access and control GP prescribing to ensure they reflect national prescribing guidelines (PJ, 28 February, p238).

The prescribing project in Cleveland began after GPs at the Woodside Surgery wanted their pharmacist, Elizabeth Walker, to help them address the number of patients who had been taking diazepam, nitrazepam and temazepam for a long time. Mrs Walker carried out an audit of patient records and sifted out those patients who were on long-term use, in some cases up to 20 years, who had no record of intervention with psychiatric services.

She said: “These were just ordinary people, with no mental health issues who were on these drugs.”

The patients were then written to and invited to attend a practice clinic where they would be supported in being weaned off the drugs in a structured way. They were also sent a “sleep hygiene” leaflet, which spelt out simple advice for having a good night’s sleep. Patients were reminded to relax towards the end of the evening and not to drink coffee late at night.

Perhaps surprisingly the pack was the only catalyst which some patients needed to wean themselves off the drugs. Mrs Walker said: “Some of the patients would come in and say to me ‘I have gone down from two to one and a half tablets’. At the clinic we would spend time talking to them but it was the patient who made the final decision. The significance, I think, was that we were supporting those patients who were interested in being helped.

“ The practice was also supportive because it was something which the GPs wanted me to look at.”

Behavioural therapy training

She suggested that other pharmacists who are keen to introduce a similar scheme might consider having some cognitive behavioural therapy training.

“I hope that I am able to empathise with people but I think some formal cognitive behavioural therapy would be useful. I probably could have benefited from some specialist training beforehand.”

Stephen Childs, the PCT’s director of primary and community services, said local GPs were committed to reducing benzodiazepine prescribing and meeting government guidelines but were pressed for time.

He admitted: “GPs don’t always feel they have got the time they need to devote to these patients — the time that is needed to counsel them off the drugs and what we want to do is bring in dedicated support.

“ I think we may end up with a combination of support provided by the practice pharmacists — who work a maximum two sessions a week in a practice — and the specialist nurse.”

He said the pharmacists are good at supporting patients who are being weaned off benzodiazepines but lack the specialist knowledge that a mental health nurse would have in managing the cause of the original problem which led to the drugs being prescribed.

Mr Childs said the benzodiazepines initiative has worked well because of the improved inter-professional relationship between GPs and pharmacists in the past two years. “Before we used to have to push the pharmacists on practices, but now the GPs can’t get enough of their support — it’s a complete turn around. I think another benefit from this is that it opens up the door for a lot more work between GPs and community pharmacists who are increasingly working with practices. I think our pharmacist team has opened up GPs’ minds about what they can offer.”

GP Carolyn Rigby, whose Woodside Surgery was involved in the original project, said the practice did not have a particularly high prescribing rate for benzodiazepines. She explained that the GPs had traditionally offered benzodiazepines on 14-day prescription but some patients who had been using the long term received their drugs on repeat prescription.

She said: “GPs are busy and we don’t always have the time to do the things as perfectly as we would like to and to have somebody like a pharmacist come in to do this work for us is extremely useful.”

She said the practice was now trying to persuade all its patients who have been on long-term benzodiazepines to have only a two-week prescription.

Back to Top


Home | Journals | News | Notice-board | Search | Site Map | Contact us

©The Pharmaceutical Journal